前苏联专利SU1414850A1 Diamine complex of platinum (ii) manifesting antitumor activity

专利PDF首页>>前苏联专利

专利附录

专利说明

权利要求

类似技术

同族专利

引用文献

法律状态

优先权

专利摘要:
This invention relates to novel platinum-diamine complexes having the formula: <IMAGE> (1) wherein R1 and R2 independently of each other may be selected from the group consisting of hydrogen, an alkyl group having 1-20 carbon atoms, a cycloalkyl group having from 3-7 carbon atoms in the ring, an aralkyl group, and an aryl group having 1-20 carbon atoms, whereas R1 and R2 together may form a cycloalkyl group having 3-7 carbon atoms in the ring and having the formula: <IMAGE> (1a) wherein N is 2 to 7 and wherein R3 and R4 independently of each other are selected from the group consisting of hydrogen, an alkyl group having 1-20 carbon atoms, an aryl group or an aralkyl group having 1-20 carbon atoms in the alkyl group and X is an anionic group, providing that when X is either chlorine or malonate, R1, R2, R3 and R4 are not each H; when X is chlorine and R1 and R2 are each H, R3 and R4 are not each methyl; when X is chlorine and R1 and R2 are each methyl, R3 and R4 are not each H, and when X is chlorine R1 is hydrogen and R2 is methyl and R3 and R4 are not each hydrogen.
公开号:SU1414850A1
申请号:SU833585700
申请日:1983-05-04
公开日:1988-08-07
发明作者:Берг Ян；Ян Бюльтен Эрик；Вербек Франсуа
申请人:Недерландзе Сентрале Организати Фор Тегепаст-Натурветеншаппелийк Ондерцоек (Фирма)；
IPC主号:

专利说明:

00
ate
The invention relates to new compounds, namely, platinum (II) diamine complexes exhibiting antitumor activity.
The purpose of the invention is to search for new and out compounds, showing a higher antitumor activity in comparison with the known ones.
Example 1. Cis-Cyclopentamethylene malonate-1,1-di (aminomethyl) cyclohexaneplatin (II).
20.65 g of cis-diyod-151 di (amino-metsh1 (cyclopentaneplatinum (II) is added to a solution of 11.55 g of AgNOj in 85 mp of water. Then the solution is stirred for 10 min at 95-100 ° C., Agl is filtered and washed while the filtrate is hot, a solution of 5J 0323 g of cyclopentamethylene malonic acid in 14.34 ml 0.511 25 and NaOH is added to it and the mixture is heated s for 12 min at 95-100 C. Then the mixture is cooled, the residue is filtered off suction and washed with water. After drying under reduced pressure, the resulting product is extracted with 4 l of methanol, the methanol solution is treated activated carbon, filtered to transparency and the resulting filtrate is evaporated to dryness under reduced pressure. The residue is suspended in 500 ml of alcohol; filtered off with suction and washed with methanol. Yield 4.75 g
The results of the elementary analysis (wt.%):
Calculated,%: C 37.86; H 5.56; ; N 5.52; Pt 38.46.
Found,%: C 37.50; H 5.50; N 5.60; Pt 38.19.
CH2 (ring): 1.3 broad singlet; CH.J (near nitrogen): 2.3 broad peak W-y: three peaks 5.3; 4.7 and 5.9,
All the resulting compounds are very pale yellow tally crystals
Example 2. Cis-D1-chloro- (2- -methyl-2-ethyl) -1., 3-propanediamine platinum (II) of the formula
SNS C1
: / / H
), pX)
CH3-CH2 CH2-KH2 C1
psuchuyut, coming from (2 methyl - 2-ethyl) -1,3-propanediamine.
To a solution of 8.05 g of K PtCl4 in 80 ml of water is added a solution of 13.2 g of KI in
10 ml of water and the mixture is heated for 5 minutes in a water bath at. After this, 2.5 g of 2-methyl--2-ethyl-1,3-diaminopropane are added and, after stirring the resulting mixture for 5 minutes at 95 ° C, the precipitate is sucked off and washed with water (3x) with cold ethanol (2x) and ether (2x) with the formation of 9.5 g (84 wt.%) cis-diiod- (2-methyl-2-ethyl) -1,3-propane-aminplatinum (II).
5.65 g of the diiodine derivative is added to a solution of 3.23 g of AgNC in 25 ml of water. After stirring the solution for 10 minutes at 95 ° C (protected from light), the Agl is filtered off and washed with water.
1.64 g of CK is added to the clear filtrate and the mixture is stirred for 12 minutes at 95 ° C. After cooling, the precipitate is filtered off with suction and washed with water. Yield 2.1 g (55 wt.%).
Calculated,%: C 18.86; H 4.22; N 7.33; PC 51.04; C1 18.85.
Found,%: C 18.73; H 4.14, N 7.26; Pt 51.33; C1 18.69.
0.8 singlet + triplet; CH2 (ethn1): 1.2 quartet; CH2 (nitrogen) 2 ,, 1 triplet; NH: three peaks 4.9; 5.5 and 4.2.
Example 3, CIS-dichloro-2,2-diethyl-1 Z-propanediamineplatinum (TI) of the formula
CH2 CHo-NH Ci
/ /
G wg
L
CH2 CH2-NH2 C1
SI
0
five
0
get, the outcome, from 2, 2-diethyl-1,3-β-propanediamine.
To a solution of 4.45 g of KjPtCL in 45 mp of water, a solution of 7.11 g of KI in 5 ml of WATER is added and the mixture is heated for 5 minutes in a water bath. After that, 1.55 g of bis-2- -ethyl- 1, 3-diamiiopropane are added and, after stirring the mixture for 5 min at 95 ° C, the precipitate is sucked off and washed with water (3x), cold ethanol (2x) and ether ( 2x) with the formation of 4.2 g (72 Maci%) cis-diiodo-2,2-α-diethyl-1,3-diaminopropane platinum (II).
3 g of the diode derivative is added to a solution of 1.53 g of AgNOj in 12 ml of water. After stirring for 10 minutes at 95 ° C (while protecting against
light action) Agl filter and:
washed with water.
0.745 g of KCl is added to the clear filtrate and the mixture is stirred for 12 minutes at 95 ° C. After cooling the mixture, the precipitate is filtered off with suction and washed with water.
Output 1.4 g (70 wt.%).
Vyisleno,%: C, 21.22; H 4.58; N 7.07; Pt 49.24; C1 17.89.
Found,%: C 21.04; H 4.50; N 7.02; / Pc 49.43; C1 17.83.
2 SNS: 0.8 multiplet; CH2 (ethl1): 1.8 multiplet; nitrogen) 2.2 triplet; three peaks of 4.9; 5.5 and 4.3.
Example 4. CIS-Dichloro-1,1-di (aminomethyl) cyclopentaneplatinum (II) of the formula
Q (
OH2- / H2
(PI
receive, starting from 1, (aminomethyl) cycpentane.
To a solution of 3.6 g of KyPtCl in 35 ml of water is added a solution of 5.7 g of KI in 8.5 ml of water and the mixture is heated for 5 minutes at 95 s in a water bath.
After that, 1.1 g of 1,1- -di (aminoethyl) cyclopentane is added and after stirring the mixture for 5 minutes at 95 ° C, the precipitate is sucked off and washed with water (3x), cold ethanol (2x) and ether (2x) with the formation of 3.5 g (70 wt.%) CIS-diyod-1, -1-di (aminoethyl) cyclopentaneplatinum.
3.2 g of the diiodo derivative is added to a solution of 1.83 g of AgNO in 15 mp of water. After stirring the solution for 10 minutes under (when protected from light), Agl is filtered off and rinsed with water. 0.9 g of KCl is added to the clear filtrate and the mixture is stirred for 12 minutes at 95 ° C.
After cooling the mixture, the precipitate is sucked off and rinsed with water. Yield 1.6 g (76 wt.%).
Calculated,%: C 21.33; H 4.09; N 7.11; Pt 49.49; C1 17.98.
Found, -%: C 21.36; H 4.10; N 7.14; Pt 49.27; C1 17.91.
SNL (ring): 1.5 multiplet; nitrogen): 2.2 triplet; NHj: three peaks 4.9; 4.3 and 5.5.
PRI me R 5, CIS-1, 1-Di (aminomethyl) cyclohexaneplatin (II) sulfate of the formula
(| y;
, yCH2-NH2
(l Ptso.
- CH2-NH2
2 g diiodo derivative
-4 / CH2-NH2X. / J W CH2-NH2 3
suspended in 150 ml of water.
After stirring for 20 hours, 1.0 g of AgjSO2 of Agl is filtered off and washed with HjO. The clear filtrate is evaporated.
Yield 1.1 g (80% by weight).
Calculated,%: C 22.17; H 4.19; N 6.46.
Found,%: C 22.02; H 4.62; N 6.31.
CH2 (ring): 1.4 broad singlet; SI2 (nitrogen): 2.2 broad peak; CNG: 4.5-6.5 wide signal.
Example 6. CIS-Dichloro-1,1-di (aminomethyl) cyclobutaneplatin (II) formula
/. CH2-NH2 C1
x R
/ SNO-NH C1
(V)
2.8 g of 1,1-di (aminomethyl) cyclobutane, 2 g of HCl and 6.2 g are dissolved in 50 ml of water, heated to 95-100 ° C and 1.2 g of dropwise are added to the solution. NaOH in 25 ml of water is so fast as to maintain the pH at t 6. The resulting precipitate is filtered by suction and washed50
55
watered and dried. The resulting product is placed in 250-300 ml of NH solution and filtered. After evaporation of the NH, the product is washed with 2N HCl, with water and dried.
The output of 3.7 g (65 wt.%).
Calculated,%: C 18.96; H 3.71; N 7.37; Pt 51.31; C1 18.65.
Found,%: C 18.95; H 3.67; N 7.37; Pt 51.02; C1 18.47.
5141A850
CH (rings): 1.4 broad singlet; CHj (on nitrogen): 2.4 triplet; NHj: three peaks 4.9; 4.3 and 5.5.
Example 7. 1 is-Dichloro-2,2-g-dibenzyl-1,3-propane diaplatinum (II) of the formula
do in
N
N
NH, C1 rU
/ NHo Ci
(Vi)
receive, on the basis of 2,2-dibenzyl-1,3-β-propanediamine.
1.4 g of bis (2-benzyl) -1,3-diaminopropane, 0.4 g of HCl and 2.28 g of KjPtCl 20 MP of water heated to
is dissolved in 95 ° C and a solution of 0.5 g of NaOH in 15 ml of water is added dropwise to the mixture so quickly to maintain the pH at t6.
After cooling, the precipitate is filtered off with suction, washed with water and dried. Product
dissolved in 200-250 ml of liquid and filtered. After the above-mentioned NH,
NIN NHj product is washed with 2 N HC1 solution, with water and dried.
Yield 1.3 g (45 wt.%).
Calculated,%: C 39.24; H 4.26; N 5.38.
Found,%: C 39.81; H 4.38; N 5.73.
CNG (nitrogen): 2.3 broad peak; CHj (benzyl): blocked by DMSO; NH: tp peak 5.1; 4.5 and 5.7.
Example B. cis-Dichloro-2,2- -diya 3 opr opil-1,3 pr, op and diamine (II) formula
SNS
CH CH2-NH2 C1 CHs
SNS / /
snr-kno C1
CH5
(Vii)
Found,%: N 5.55.
Example
1,1-Di (aminoG
1.6 g of bis (2-isopropyl) 1,3-diaminopropane, 0.73 g of HCl and 4.15 g of KiPcCLf go methyl) cyclohexanmalonato1shatin (II),
having a formula
ABOUT
dissolved in
and to this solution by
50 mi water heated to
drop m
a solution of 0.9 g of NaOH in 10 ml of water is added so quickly that the pH is maintained at a value of ± 6. The precipitate formed is filtered off with suction and washed with water. After drying, the product is dissolved in 250-300 MP of liquid ammonia and filtered. After drilling
0 (,
CH2NH2 pV /
OCH2-NH2 0-C O
g
%: C, 25.48; H 5.23; : C 26.31; H 5.39;
0
15
0
The product was washed with a 2 N HC1 solution, water, and dried.
The output of 1.0 g (24 wt.%).
Calculated N 6.60.
Found 5, N 6.90.
Example 9. CIS-Dichloro-2,2-β-diisopropyl-1,3-propanediamineplatinum (II) of formula (VIII) is prepared starting from 2,2-diisopropyl-1,3-propanediamine, as in Example 6.
Calculated,%: C 25.48; H 5.23; N 6.60.
Found,%: C 26.31; H 5.39; N 6.90 ..
CHj: 0.9 doublet; NH signal ..
Example 10. 1,1-Di (amine tyl) cyclohexane bis (chloroacetate) platinum (II) having the formula
ji 4,6 wide
-But
about
nu.nh2 o
CH2-NH2 0
ABOUT
II
C-CHgCl. (Vlir) C-ChbCl
II o
1.6 g of the dichloro derivative obtained according to Example 2 (formula IV) are added to a solution of 1.28 g of AgNGj in 25 MP of water. After stirring the mixture for 1 h at AgCl2, it is filtered and washed with water. A solution of 0.73 g of monochloroacetic acid and 0.45 g of KOH in 25 ml of water is added to the clear filtrate and the mixture is stirred for 2 hours at room temperature. The precipitate is filtered off with suction and washed with water. The output of 1.3 g (65 wt.%).
Calculated,%: C 27.49; H 4.23;
N
5.34,
Found,%: N 5.55.
Example
C, 27.43; H 4.21;
1,1-Di (aminoG
methyl) cyclohexane malonato 1 shatin
0 (,
CH2NH2 pV /
OCH2-NH2 0-C O
1.6 g of dichloro derivative
../
7
CH2-NH2
R

C1
C1
1.28 g of AgNC are added to a solution of 25 ml. water. After stirring the mixture for 1 h at 40 ° C, the AgCl is filtered off and washed with water. A solution of 0.4 g of malonic acid and 0.455 g of KOH in 10 ml of water is added to the clear filtrate. After stirring for 2 hours at room temperature, the precipitate is filtered off and dried. Yield 1.0 g (59 wt.%).
Calculated,%: C 30.07; H 4.59; N 6.38; Pt 44.40; About 14.57.
Found,%: C 29.98; H 4.54; N 6.32; PC 44.32; About 14.57.
The table also shows the compound of the formula
ABOUT
eleven
NH2 O-C
R
NH2 0-С
ABOUT
)about
: (x)
414850 °
the most dangerous and limits the dosage that can be applied in practice.
The proposed compounds do not have any harmful side effects on the kidneys. This was established by histological examination of rats after exposure to toxic doses of new compounds, whereas in a similar study with schCH, serious kidney damage was found.
New complexes do not have also
15 and the adverse effects on kidney function. - The main method for determining renal toxicity is to assess the th-percentage amount of urea nitrogen in the blood (urea
20 blood nitrogen, BUN), which is also defined as NPN non-protein nitrogen.

权利要求:
Claims (1)
[1]
Invention Formula
25 Platinum (II) diamine complexes of general formula
R, CH.-NH. BUT
SNg-NH, /
/
R,
/ H
CHj-NH
Pi / H
Studies show that the proposed compounds have a high therapeutic activity against cancer. In contrast to the platinum complexes used to fight cancer, such as cis-platinum diamine diachloride (PDC), it has also been found that the proposed compounds show only little toxicity to the kidneys or do not show it at all.
The novel compounds show antitumor activity against a large number of different types of tumors, such as P-388 lymphocyte leukemia, L 1210 lymphoid leukemia, epedymoblastoma and B 16 melanocarcinoma. The therapeutic activity of new compounds is higher than that of PDC, which is used as an experimental clinical chemotherapeutic agent (table).
The disadvantage of practical use of PDC, like all other known antitumor platinum complexes, is high toxicity, and renal toxicity is
where R - RI -
R Rj - - 5R R2 - from CjH ,, then X is chlorine, or when R, R - CjHj, then 2X
or when R and R together form a 4-b-membered cyclic ring, then X is chlorine, 2X is SO /, or
O -0-C-CH2C1
about
5 -O-С
-o-s
) or
about
-O-C-SNGSG
about
exhibiting antitumor activity.
Priority signs: 06.07,78 2x SO or
ABOUT
55
-O-C
CPS
by
Fdd
BgDjCBDF)
I
PDD
PDD
,
, 57BL / 6
, CDjF, CD, F, CDjFy BDF,
BDF, BDF BDF,
BDF, BDF BDF BDF,
PS
E EM
LE
LE
LE
LE
LE
LE
LE
LE
LE LE / cis PDD
LE Le / cis PDD
n p I.M e h a nor e. LE - 1210 lymphoid leukemia; EM - epidimoblastoma;
B - B j. - melanocarcinoma; d is the survival period of the processed ones (t) in relation to the untreated ones (C); therapeutic activity is significant at T / C 7 / 12.4.
2.00 5.00 12.50
6.25 0.00 12.50 6.25 12.50 12.50 12.50 12.50 15.00 0.00 0.00
6.00 4.00 16.00
8.00
4-8
197 226 177 162 138 163 130 289 323 148 274 208 135 178 207
200 (1/6) 230 183 106-121

类似技术:

公开号 | 公开日 | 专利标题

SU1414850A1|1988-08-07|Diamine complex of platinum | manifesting antitumor activity

US4562275A|1985-12-31|Antitumor platinum complexes

US4482569A|1984-11-13|Platinum |-diamine complexes, a process for the preparation of pharmaceutical compositions and a method of treating malignant tumors in mice

CA1340286C|1998-12-22|Pt| complexes

US5072011A|1991-12-10|Pt| complexes

Hoeschele et al.1994|Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum | chelate complexes incorporating the cis-1, 4-diaminocyclohexane ligand in a unique locked boat conformation

KR910002536B1|1991-04-23|Preparation method of plantinum-diamine complexes

Reventos et al.1986|Substituted cyclopentadienylruthenium complexes containing | donor ligands

US4182724A|1980-01-08|Compositions containing platinum

CA2027792A1|1991-04-18|Water and solvent soluble axial hydroxy and mono- and di-carboxylic acid derivatives having high tumor activity

Morikawa et al.1990|Synthesis and antitumor activities of platinum complexes of unsymmetrical alicyclic diamines as carrier ligands

CA2070497C|1999-05-25|Novel platinum | complex and antitumor agent

Mahmood et al.1998|Synthesis and X-ray crystal structures of Schiff bases prepared from salicylaldehyde and the diamino acids L-2-amino-3-methylaminopropanoic acid, DL-2, 4-diamino-butanoic acid and DL-2, 3-diaminopropanoic acid

KR840000777B1|1984-06-09|A process for the preparation of platinum diamine complex

AT390058B|1990-03-12|METHOD FOR PRODUCING NEW DIAMINE-PLATIN | COMPLEX COMPOUNDS WITH A HYDROXYLATED 2-PHENYL INDOLRING

CA1196004A|1985-10-29|Platinum-diamine complexes, a method for thepreparation thereof, a method for the preparation ofa medicine using such a platinum-diamine complex forthe treatment of cancer as well as a medicine thusformed

EP0346368A1|1989-12-20|Polymetallic molecular systems with ferromagnetic properties

CA1097670A|1981-03-17|Compositions containing platinum

US4797485A|1989-01-10|Platinum-flavin anti-tumor complexes

Kojiyutoh et al.1996|NEW TRIAMINE-TYPE PLATINUM | COMPLEXES OF PHENYL-SUBSTITUTED ETHYLENEDIAMINE: REACTIVITY WITH 5′-GMP

RU2007413C1|1994-02-15|Method of producing antitumor platinum complexes

Mijajlović et al.2016|Cytotoxicity of Platinum | and Palladium | Complexes with Meso-1, 2-Diphenyl-Ethylenediamine-N, N-Di-3-Propanoic Acid. Crystal Structure of [Pd |] Complex

Sultana2018|Zinc | complexes of sulfonamides as antibacterial agents: Design, characterization and biological activity

Arsenijević et al.2016|CYTOTOXICITY OF PLATINUM | AND PALLADIUM | COMPLEXES WITH meso-1, 2-DIPHENYL-ETHYLENEDIAMINE-N, N'-DI-3-PROPANOIC ACID.

EP0386243A1|1990-09-12|Platinum | complexes

同族专利:

公开号 | 公开日

ES482240A1|1980-10-01|

ATA469079A|1984-07-15|

SU1160937A3|1985-06-07|

DE2927056C2|1990-08-30|

NO163898B|1990-04-30|

ES490630A0|1980-12-01|

YU41652B|1987-12-31|

DK284979A|1980-01-07|

HK9986A|1986-02-14|

FR2430406B1|1983-12-30|

KE3590A|1986-02-07|

NO163898C|1990-08-22|

FR2430406A1|1980-02-01|

GB2024823A|1980-01-16|

AU4867979A|1980-02-07|

GB2024823B|1982-12-08|

DE2927056A1|1980-01-24|

MY8600400A|1986-12-31|

LU81470A1|1980-02-14|

FR2511685A1|1983-02-25|

NO792240L|1980-01-08|

JPS5513280A|1980-01-30|

DK153540B|1988-07-25|

PH21386A|1987-10-15|

AT377251B|1985-02-25|

FR2511685B1|1985-10-18|

PT69877A|1979-08-01|

AR226709A1|1982-08-13|

NZ190923A|1981-01-23|

IL57717D0|1979-11-30|

BE877527A|1980-01-07|

ES8101079A1|1980-12-01|

IT7924099D0|1979-07-04|

IT1122011B|1986-04-23|

GR69248B|1982-05-11|

IE791271L|1980-01-06|

FI792127A|1980-01-07|

ES8101080A1|1980-12-01|

SE7905927L|1980-01-07|

CY1320A|1986-06-27|

CA1152088A|1983-08-16|

CH641758A5|1984-03-15|

NL7807334A|1980-01-08|

SG91685G|1986-07-25|

CS235301B2|1985-05-15|

DK153540C|1988-12-05|

IL57717A|1983-09-30|

US4410544A|1983-10-18|

AU533539B2|1983-12-01|

FI76350B|1988-06-30|

ES490629A0|1980-12-01|

DD144780A5|1980-11-05|

CH649525A5|1985-05-31|

ZA793394B|1980-06-25|

IE48519B1|1985-02-20|

YU166279A|1983-01-21|

HU183014B|1984-04-28|

JPS648636B2|1989-02-14|

FI76350C|1988-10-10|

引用文献:

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

DE4415263C1|1994-04-15|1995-11-30|Asta Medica Ag|Cis- [trans-1,2-cyclobutane bis-N, N '] - [ -lactato-O · 1 ·, O · 2 ·] -platinumtrihydrate , its manufacture and medicinal use|GB1432562A|1972-04-10|1976-04-22|Rustenburg Platinum Mines Ltd|Platinum co-ordination compounds|

GB1432563A|1972-04-10|1976-04-22|Rustenburg Platinum Mines Ltd|Platinum- co-ordination compounds|

CH588505A5|1972-06-08|1977-06-15|Research Corp|

JPS5829957B2|1977-09-12|1983-06-25|Yoshinori Kitani|JPS56154493A|1980-04-30|1981-11-30|Shionogi & Co Ltd|Novel platinum complex|

NZ197104A|1980-05-27|1984-05-31|Bristol Myers Co|Soluble ammonium and sodium salts of 2-hydroxymalonato platinum ii derivatives|

NL8101026A|1981-03-03|1982-10-01|Tno|PLATINADIAMINE COMPLEXES, A METHOD FOR PREPARING THE SAME, A METHOD FOR PREPARING A MEDICINAL PRODUCT USING SUCH PLATINADIAMINE COMPLEX FOR THE TREATMENT OF CANCER AND CONTAINED IN SUCH FORM.|

US4786725A|1982-06-28|1988-11-22|Engelhard Corporation|Solubilized platinumcomplexes|

NL8204067A|1982-10-21|1984-05-16|Tno|PLATINUM DIAMINE COMPLEXES, METHOD FOR PREPARING THE SAME, METHOD FOR PREPARING A MEDICINAL PRODUCT USING SUCH PLATINADIAMINE COMPLEX FOR THE TREATMENT OF CANCER, PREVENTLY PREVENTED.|

DE3305248C2|1983-02-16|1987-04-09|Degussa Ag, 6000 Frankfurt, De|

US4598091A|1983-02-18|1986-07-01|Degussa Aktiengesellschaft|-ethylenediamine)-platinumcomplex compounds|

US4565884A|1983-05-10|1986-01-21|Andrulis Research Corporation|Bis-platinum complexes as antitumor agents|

US4720504A|1983-05-10|1988-01-19|Andrulis Research Corporation|Use of bis-platinum complexes as antitumor agents|

JPH0469636B2|1983-05-10|1992-11-06|Andorurisu Risaachi Corp|

US4758588A|1983-06-20|1988-07-19|Research Corporation Technologies|Diaminocyclohexane platinum complexes|

US4661516A|1983-06-20|1987-04-28|Research Corporation|Diaminocyclohexane platinum complexes|

US4562275A|1984-03-23|1985-12-31|Bristol-Myers Co.|Antitumor platinum complexes|

EP0169645A1|1984-06-27|1986-01-29|Johnson Matthey Public Limited Company|Platinum co-ordination compounds|

US4952676A|1984-06-27|1990-08-28|Johnson Matthey Plc|Monoclonal antibody-platinum co-ordination compound complex|

DE3432320A1|1984-09-03|1986-03-13|Behringwerke Ag, 3550 Marburg|CIS-PLATINUM COMPLEXES WITH A PENTAERYTHRITE DERIVATIVE AS A LIGAND, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENT CONTAINING THESE COMPOUNDS|

HU193809B|1984-09-12|1987-12-28|Chugai Pharmaceutical Co Ltd|Process for producing new platinum complexes|

US4665210A|1984-12-17|1987-05-12|American Cyanamid Company|Platinum complexes of aliphatic tricarboxylic acids|

US4739087A|1985-01-10|1988-04-19|Bristol-Myers Company|Antineoplastic platinum complexes|

US4567285A|1985-07-10|1986-01-28|Yoshinori Kidani|Complex compounds of platinum|

JPH0523276B2|1985-08-27|1993-04-02|Nippon Kayaku Kk|

US4737589A|1985-08-27|1988-04-12|Nippon Kayaku Kabushiki Kaisha|Platinum Complexes|

US4970324A|1985-12-24|1990-11-13|Hoeschele James D|Aminoalkyl-substituted azetidine platinum complexes|

US5116831A|1985-12-24|1992-05-26|Warner-Lambert Company|Aminoalkyl-substituted cycloalkylamine platinumcomplexes|

US4760157A|1986-01-31|1988-07-26|American Cyanamid Company|-1,3-propanediol-N,N')platinum complexes|

US4880790A|1986-01-31|1989-11-14|American Cyanamid Company|platinum complexes|

US4716157A|1986-03-20|1987-12-29|American Cyanamid Company|Heterocyclic-1,2-diamine platinum complexes|

DE3630497A1|1986-09-08|1988-03-10|Behringwerke Ag|CIS-PLATINUM COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS|

US4870070A|1987-08-10|1989-09-26|American Cyanamid Company|Water soluble platinum complexes of novel malonate derivatives|

AT390065B|1987-10-08|1990-03-12|Behringwerke Ag|cis-Platinum complexes, process for their preparation and pharmaceutical compositions containing these compounds|

ES2054778T3|1988-01-09|1994-08-16|Asta Medica Ag|1,2-BISCYCLOBUTANE-PLATINUM COMPLEXES.|

NL8802150A|1988-08-31|1990-03-16|Tno|PLATINUMDIAMINE COMPLEX, PROCESS FOR PREPARING THIS COMPOUND, PREPARATION WITH ANTI-TUMOR EFFECT, CONTAINING THIS COMPOUND AND FORMED PREPARATIONS WITH ANTI-TUMOR EFFECT.|

NL8802149A|1988-08-31|1990-03-16|Tno|PLATINUMDIAMINE COMPLEX, METHOD FOR PREPARING THIS COMPOUND, PREPARATION WITH ANTI-TUMOR EFFECT, CONTAINING AT LEAST A PLATINUM COMPOUND, AND FORMED PREPARATIONS WITH ANTI-TUMOR EFFECT.|

US4895960A|1989-01-23|1990-01-23|University Of Cincinnati|Cyclo substituted propyleneamine oxime and its use as a brain imaging agent|

法律状态:

优先权:

申请号 | 申请日 | 专利标题

NL7807334A|NL7807334A|1978-07-06|1978-07-06|PLATINUM DIAMINE COMPLEXES, METHOD FOR PREPARING THE SAME, METHOD FOR PREPARING A MEDICINAL PRODUCT USING SUCH A PLATINUM DIAMOND COMPLEX FOR THE TREATMENT OF CANCER, SO PREVENTLY DRIVED.|

[返回顶部]